Effects of Ginkgolide A on Okadaic Acid-induced Tau Hyperphosphorylation and the PI3K-Akt Signaling Pathway in N2a Cells

Abstract

Alzheimerʼs disease is the most common form of dementia leading to the irreversible loss of neurons, and Tau hyperphosphorylation has an important role in the pathology of Alzheimerʼs disease. Ginkgolide A is one of the active components of Ginkgo biloba extracts which has been proven to have neuroprotective effects, but the effect of ginkgolide A on Tau hyperphosphorylation has not yet been reported. In this study, the effects of ginkgolide A on cell viability, Tau hyperphosphorylation, and the PI3K-Akt signaling pathway in N2a cell lines were explored, and methods such as the MTT assay, ELISA, and Western blots techniques were used. The results showed that ginkgolide A could increase cell viability and suppress the phosphorylation level of Tau in cell lysates, meanwhile, GSK3β was inhibited with phosphorylation at Ser9. Moreover, treatment of the cells with ginkgolide A promoted phosphorylation of PI3K and Akt, suggesting that the activation of the PI3K-Akt signaling pathway may be the mechanism for ginkgolide A to prevent the intracellular accumulation of p-Tau induced by okadaic acid and to protect the cells from Tau hyperphosphorylation-related toxicity.

Key words

ginkgolide A - Tau hyperphosphorylation - N2a cells - PI3K-Akt signaling pathway

• References

• 1 Saleem S, Zhuang H, Biswal S, Christen Y, Dor S. Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury. Stroke 2008; 39: 3389-3396
• 2 DeFeudis FV, Drieu K. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr Drug Targets 2000; 1: 25-58
• 3 Nin YH, Yang XY, Bao WS. Protective effects of Ginkgo biloba extract on cultured rat cardiomyocytes damaged by H₂O₂ . Acta Physiol Sin 1999; 20: 635-638
• 4 Bastianetto S, Zheng WH, Quirion R. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells nitric oxide induced toxicity: involvement of its flavonoid constituents and protein kinase C. J Neurochem 2000; 74: 2268-2277
• 5 Guidetti C, Paracchini S, Lucchini S. Prevention of neuronal cell damage induced by oxidative stress in vitro: effect of different Ginkgo biloba extracts. Pharmacology 2001; 53: 387-392
• 6 Armstrong RA. Plaques and tangles and the pathogenesis of Alzheimerʼs disease. Folia Neuropathol 2006; 44: 1-11
• 7 Selkoe DJ. Alzheimerʼs disease is a synaptic failure. Science 2002; 298: 789-791
• 8 Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci 2001; 24: 1121-1159
• 9 Lee VM, Balin B, Otvos jr. L, Trojanowski JQ. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 1991; 251: 675-678
• 10 Yates D, McLoughlin DM. The molecular pathology of Alzheimerʼs disease. Psychiatry 2008; 7: 1-5
• 11 Bertrand J, Plouffe V, Senechal P, Leclerc N. The pattern of human Tau phosphorylation is the result of priming and feedback events in primary hippocampal neurons. Neuroscience 2010; 168: 323-334
• 12 Drubin DG, Kirschner MW. Tau protein function in living cells. J Cell Biol 1986; 103: 2739-2746
• 13 Zhao RP, Zhang ZX, Song YJ, Wang DS, Qi JP, Wen SR. Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3β pathway in ginsenoside Rb1′s attenuation of beta-amyloid-induced neurotoxicity and Tau phosphorylation. J Ethnopharmacol 2011; 133: 1109-1116
• 14 Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997; 275: 661-665
• 15 Lee JH, Hong HN, Im JO, Byun HS, Kim DH. The formation of PHF-1 and SMI-31 positive dystrophic neurites in rat hippocampus following acute injection of okadaic acid. Neurosci Lett 2000; 282: 49-52
• 16 Mudher AK, Perry VH. Using okadaic acid as a tool for the in vivo induction of hyperphosphorylated Tau. Neuroscience 1998; 85: 1329-1332
• 17 Pei JJ, Gong CX, An WL, Winblad B, Cowburn RF, Grundke-Iqbal I, Iqbal K. Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimerʼs disease. Am J Pathol 2003; 163: 845-858
• 18 Greco SJ, Sarkar S, Casadesus G, Zhu XW, Smith MA, Ashford JW, Johnston JM, Tezapsidis N. Leptin inhibits glycogen synthase kinase-3β to prevent Tau phosphorylation in neuronal cells. Neurosci Lett 2009; 455: 191-194
• 19 Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH. Glycogen synthase kinase-3 induces Alzheimerʼs disease-like phosphorylation of Tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett 1992; 147: 58-62
• 20 Baki L, Shioi J, Wen P, Shao ZP, Schwarzman A, Gama-Sosa M, Neve R, Robakis NK. PS1 activates PI3K thus inhibiting GSK-3 activity and Tau overphosphorylation: effects of FAD mutations. EMBO J 2004; 23: 2586-2596
• 21 Cardona-Gomez GP, Mendez P, Garcia-Segura LM. Synergistic interaction of estradiol and insulin-like growth factor-I in the activation of PI3K/Akt signaling in the adult rat hypothalamus. Brain Res Mol Brain Res 2002; 107: 80-88
• 22 Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995; 378: 785-789
• 23 Rafii MS, Aisen PS. Recent developments in Alzheimerʼs disease therapeutics. BMC Med 2009; 7: 7
• 24 Hanger DP, Seereeram A, Noble W. Mediators of Tau phosphorylation in the pathogenesis of Alzheimerʼs disease. Expert Rev Neurother 2009; 9: 1647-1666
• 25 Hanger DP, Anderton BH, Noble W. Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol Med 2009; 15: 112-119
• 26 Takashima A. GSK-3β is essential in the pathogenesis of Alzheimerʼs disease. J Alzheimers Dis 2006; 9: 309-317
• 27 Reynolds CH, Betts JC, Blackstock WP, Nebreda AR, Anderton BH. Phosphorylation sites on Tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J Neurochem 2000; 74: 1587-1595
• 28 Chan TO, Rittenhouse SE, Tsichlis PN. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem 1999; 68: 965-1014
• 29 Brunet A, Datta SR, Greenberg ME. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 2001; 11: 297-305
• 30 Kaytor MD, Orr HT. The GSK3 beta signaling cascade and neurodegenerative disease. Curr Opin Neurobiol 2002; 12: 275-278
• 31 Ahlemeyer B, Krieglstein J. Neuroprotective effects of Ginkgo biloba extract. Cell Mol Life Sci 2003; 60: 1779-1792
• 32 Shi C, Zhao L, Zhu B, Li Q, Yew DT, Yao Z, Xu J. Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against beta-amyloid peptide-induced toxicity in SH-SY5Y cells. Chem Biol Interact 2009; 181: 115-123